Advertisement
Screener

LIQUIDIA CORPORATION (LQDA) EBITDA

LIQUIDIA CORPORATION (LQDA) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $85.92M*; Operating income $85.52M; Depreciation and amortization $400.00K*.
  • 2026-03-31: Basis Reported; EBITDA $62M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $20.11M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $2.24M*; Operating income $1.77M; Depreciation and amortization $476.00K*.

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$85.92M*$85.52M$400.00K*$171.68M50.05%*$11.23M*$80.24M*(m)$17.18M$57.43M$6.97M
2026-03-31Reported$62M(m)(m)(m)46.66%$2.83M$52.99M(m)$12.57M$46.94M$3.92M
2025-12-31Reported$20.11M(m)(m)(m)21.85%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$2.24M*$1.77M$476.00K*$54.34M4.13%*$911.00K*-$9.77M*(m)$9.35M$40.06M(m)
2025-06-30Reported-$37.22M*-$37.51M$281.00K*$8.84M-421.23%*$1.06M*-$39.48M*(m)$6.02M$38.82M$0.00
2025-03-31Reported-$34.97M(m)(m)(m)-1120.96%$330.00K-$30.68M$1.52M$6.97M$30.06M$0.00
2024-12-31Reported-$35.59M(m)(m)(m)-1220.05%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$28.58M*-$29.19M$610.00K*$4.45M-642.51%*$1.75M*-$25.08M*$1.56M$11.89M$20.18M(m)
2024-06-30Reported-$26.62M*-$27.20M$580.00K*$3.66M-727.44%*$1.29M*-$22.66M*$1.49M$9.42M$19.94M(m)
2024-03-31Reported-$28.31M(m)(m)(m)-952.62%$624.00K-$24.87M$1.47M$10.06M(m)(m)
2023-12-31Reported-$25.93M(m)(m)(m)-572.28%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$14.38M*-$14.89M$514.00K*$3.68M-390.89%*$475.00K*-$11.56M*$570.00K$7.44M(m)(m)
2023-06-30Reported-$22.24M*-$22.82M$589.00K*$4.79M-464.61%*$243.00K*-$5.56M*$671.00K$17.70M(m)(m)
2023-03-31Reported-$8.66M(m)(m)(m)-192.81%$366.00K-$8.46M$654.00K$5.28M(m)(m)
2022-12-31Reported-$5.93M(m)(m)(m)-110.65%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$7.70M*-$8.83M$1.13M*$3.17M-243.38%*$94.00K*-$5.77M*$740.00K$4.51M(m)(m)
2022-06-30Reported-$7.96M*-$8.97M$1.01M*$3.92M-203.27%*$7.00K*-$8.43M*$731.00K$5.22M(m)(m)
2022-03-31Reported-$13.53M(m)(m)(m)-387.31%$0.00-$9.78M$694.00K$4.73M(m)$0.00
2021-12-31Reported-$10.49M(m)(m)(m)-326.28%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$5.54M*-$7.08M$1.54M*$3.18M-174.11%*$0.00*-$5.83M*$890.00K$4.49M(m)$0.00
2021-06-30Reported-$4.77M*-$6.35M$1.59M*$3.38M-141.23%*$35.00K*-$8.26M*$714.00K$4.59M(m)$0.00
2021-03-31Reported-$7.39M(m)(m)(m)-239.69%$52.00K-$12.39M$694.00K$6.05M(m)$0.00
2020-12-31Reported-$14.96M(m)(m)(m)-2022.96%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$14.09M*-$14.81M$722.33K*$0.00(m)$122.50K*-$12.51M*$0.00$7.66M(m)(m)
2020-06-30Reported-$12.99M*-$13.72M$724.05K*$0.00(m)$408.40K*-$13.11M*$0.00$8.49M(m)$0.00
2020-03-31Reported-$13.91M(m)(m)(m)(m)$182.22K-$14.44M$0.00$10.82M(m)$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$49.85M(m)(m)(m)-31.49%$4.34M-$35.69M(m)$39.28M$157.18M$0.00
2025-09-30Rolling(m)-$107.27M*(m)$69.22M*(m)(m)(m)(m)(m)(m)(m)
2025-06-30Rolling(m)-$138.23M*(m)$19.32M*(m)(m)(m)(m)(m)(m)(m)
2025-03-31Rolling(m)-$127.92M*(m)$14.14M*(m)(m)(m)(m)(m)(m)(m)
2024-12-31Reported-$119.1M(m)(m)(m)-850.94%$4.95M-$93.42M$5.88M$47.84M$81.57M$0.00
2024-12-31Rolling(m)-$121.29M*(m)$14.00M*(m)(m)(m)(m)(m)(m)(m)
2024-09-30Rolling(m)-$111.62M*(m)$15.61M*(m)(m)(m)(m)(m)(m)(m)
2024-06-30Rolling(m)-$97.33M*(m)$14.84M*(m)(m)(m)(m)(m)(m)(m)
2024-03-31Rolling(m)-$92.95M*(m)$15.97M*(m)(m)(m)(m)(m)(m)(m)
2023-12-31Reported-$71.21M(m)(m)(m)-407.17%$1.29M-$41.56M$2.89M$43.24M$44.74M$0.00
2023-12-31Rolling(m)-$73.38M*(m)$17.49M*(m)(m)(m)(m)(m)(m)(m)
2022-12-31Reported-$35.12M(m)(m)(m)-220.41%$592.00K-$28.59M$2.86M$19.43M(m)$0.00
2021-12-31Reported-$28.19M(m)(m)(m)-219.29%$107.00K-$34.03M$3.02M$20.52M(m)$0.00
2020-12-31Reported-$55.96M(m)(m)(m)-7565.90%$752.09K-$54.14M$237.71K$32.22M(m)$0.00
2019-12-31Reported-$44.26M(m)(m)(m)-548.26%$1.85M-$48.28M(m)$40.49M(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Alkermes plc. (ALKS)$6.844B132.74
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07